38 results
Page 2 of 2
6-K
EX-99.1
emjkw nln29v
19 Sep 22
XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration
7:00am
F-1
EX-1.1
ml42wmsn7p5n6x3 208b
8 Sep 22
Registration statement (foreign)
1:02pm
F-1
eghd7
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
d5zagb1dw6yr
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.1
iltpffdbzniuqxmj520
4 Aug 22
XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration
7:00am
6-K
EX-99.2
2eutp7i5p6 6174c
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
EX-4.23
abhxkao mljaayoozj
3 May 22
Annual report (foreign)
5:29pm
20-F
qvv1g
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
dl1k1v1odi
31 Mar 22
Current report (foreign)
7:00am
424B4
898z32c
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
xzpb41
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
si9t zl3laifl
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
c2i0bjs5d7xlicv8
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1/A
EX-1.1
4zat8sn9xwy9is03vswn
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
emiyma
11 Aug 21
Registration statement (foreign)
9:55pm
DRS/A
owaw25j2 9it
21 Jul 21
Draft registration statement (amended)
12:00am
DRS
EX-3.1
rjueyqyi7 3v1uyi3lph
26 May 21
Draft registration statement
12:00am
DRS
58a1l0sgdwfka6d 3y
26 May 21
Draft registration statement
12:00am